Share Price and Basic Stock Data
Last Updated: January 24, 2026, 4:13 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kanoria Chemicals & Industries Ltd operates in the organic chemicals sector, focusing primarily on alcohol-based products. As of September 2023, the company reported a share price of ₹67.6 and a market capitalization of ₹297 Cr. The revenue from operations for the fiscal year ending March 2025 stood at ₹1,537 Cr, showing a marginal increase from ₹1,475 Cr in the previous fiscal year. Over the past several quarters, revenue trends have shown volatility, with quarterly sales peaking at ₹445 Cr in March 2023 but declining to ₹371 Cr in September 2023. The trailing twelve-month (TTM) revenue recorded was ₹1,190 Cr. Kanoria has been experiencing a fluctuating sales pattern, indicating underlying challenges in maintaining consistent demand. This inconsistency may reflect broader market conditions affecting the chemicals sector, which typically experiences cyclical trends in demand.
Profitability and Efficiency Metrics
Profitability metrics for Kanoria Chemicals reveal a challenging landscape. The company reported an operating profit margin (OPM) of just 3% for March 2025, down from 5% in the previous year, indicating tightening margins. The net profit for the same fiscal year was recorded at a loss of ₹108 Cr, a significant decline from a loss of ₹55 Cr in March 2024. The interest coverage ratio (ICR) stood at 0.88x, suggesting that the company’s earnings are insufficient to cover its interest obligations, which raises concerns regarding financial stability. Additionally, the return on equity (ROE) was reported at 11.8%, while the return on capital employed (ROCE) was a mere 2.33%, reflecting inefficiencies in utilizing capital effectively. These figures highlight the pressures Kanoria faces in terms of cost management and operational effectiveness, necessitating strategic interventions to enhance profitability.
Balance Sheet Strength and Financial Ratios
As of September 2025, Kanoria Chemicals reported total borrowings of ₹327 Cr against reserves of ₹510 Cr, indicating a reliance on debt financing, which is concerning given the total debt-to-equity ratio of 1.14x. The company recorded a current ratio of 0.99, suggesting liquidity challenges, as it falls below the ideal benchmark of 1.0 for covering short-term liabilities. The book value per share stood at ₹119.19, down from ₹141.33 in the previous year, indicating a decrease in shareholder equity. Furthermore, the company’s total assets were reported at ₹1,108 Cr, with fixed assets valued at ₹709 Cr. The enterprise value-to-EBITDA ratio was high at 22.19, suggesting that the market may perceive the company as overvalued relative to its earnings potential. These balance sheet metrics underline the financial strain Kanoria faces, necessitating careful management of debt and operational costs.
Shareholding Pattern and Investor Confidence
Kanoria Chemicals has a stable shareholding pattern, with promoters holding 74.39% of the shares, suggesting strong control by the founding family. The public holds 25.48%, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) account for only 0.04% and 0.08%, respectively. The total number of shareholders as of September 2025 was recorded at 17,555, indicating a growing interest among retail investors despite the company’s operational challenges. The low institutional participation may reflect cautious sentiment from larger investors regarding the company’s financial health and performance outlook. The consistency in promoter holding could provide some stability, but the lack of broader institutional interest raises concerns about the overall market perception of Kanoria’s growth potential. This could impact the company’s ability to raise capital for future expansions or operational improvements.
Outlook, Risks, and Final Insight
The outlook for Kanoria Chemicals is mixed, characterized by both potential opportunities and significant risks. On one hand, the company’s strong promoter backing and established presence in the organic chemicals sector can provide a platform for recovery if operational efficiencies are improved. However, the declining profitability, high debt levels, and liquidity concerns pose substantial risks that could hinder growth. If Kanoria can streamline operations and reduce costs, it may enhance its profit margins and return to a growth trajectory. Conversely, continued volatility in sales and external market pressures could exacerbate financial challenges. Investors should closely monitor the company’s strategic responses to these risks and its ability to achieve sustainable profitability in the coming quarters, as these factors will ultimately dictate its long-term viability and market standing.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Aeonx Digital Technology Ltd | 69.0 Cr. | 150 | 242/121 | 23.0 | 115 | 0.67 % | 9.78 % | 6.79 % | 10.0 |
| Kanoria Chemicals & Industries Ltd | 299 Cr. | 68.5 | 110/64.8 | 122 | 0.00 % | 2.33 % | 11.8 % | 5.00 | |
| India Glycols Ltd | 5,447 Cr. | 813 | 1,223/502 | 21.0 | 387 | 0.62 % | 12.4 % | 11.1 % | 5.00 |
| Industry Average | 2,873.00 Cr | 343.83 | 22.00 | 208.00 | 0.43% | 8.17% | 9.90% | 6.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 362 | 385 | 445 | 401 | 371 | 342 | 361 | 384 | 177 | 348 | 431 | 201 | 210 |
| Expenses | 356 | 369 | 422 | 391 | 365 | 339 | 333 | 382 | 176 | 348 | 414 | 183 | 204 |
| Operating Profit | 6 | 17 | 23 | 10 | 6 | 3 | 29 | 2 | 0 | -0 | 17 | 18 | 6 |
| OPM % | 2% | 4% | 5% | 3% | 2% | 1% | 8% | 0% | 0% | -0% | 4% | 9% | 3% |
| Other Income | -0 | 3 | -0 | 13 | -0 | 8 | 0 | 2 | 6 | 1 | -27 | -13 | 106 |
| Interest | 8 | 10 | 11 | 11 | 12 | 9 | 12 | 11 | 8 | 11 | 12 | 7 | 9 |
| Depreciation | 14 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 8 | 16 | 16 | 9 | 9 |
| Profit before tax | -17 | -5 | -3 | -2 | -21 | -13 | 2 | -22 | -9 | -27 | -38 | -10 | 95 |
| Tax % | -1% | -14% | -70% | 67% | -3% | 14% | 816% | 4% | 77% | 6% | 5% | 32% | 4% |
| Net Profit | -17 | -4 | -1 | -4 | -21 | -15 | -16 | -23 | -16 | -29 | -40 | -14 | 92 |
| EPS in Rs | -3.26 | -0.29 | -0.35 | -0.60 | -4.20 | -1.86 | -2.12 | -3.81 | -3.18 | -3.82 | -8.33 | -1.79 | 21.39 |
Last Updated: December 30, 2025, 7:35 am
Below is a detailed analysis of the quarterly data for Kanoria Chemicals & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 201.00 Cr. (Jun 2025) to 210.00 Cr., marking an increase of 9.00 Cr..
- For Expenses, as of Sep 2025, the value is 204.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 183.00 Cr. (Jun 2025) to 204.00 Cr., marking an increase of 21.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Jun 2025) to 6.00 Cr., marking a decrease of 12.00 Cr..
- For OPM %, as of Sep 2025, the value is 3.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Jun 2025) to 3.00%, marking a decrease of 6.00%.
- For Other Income, as of Sep 2025, the value is 106.00 Cr.. The value appears strong and on an upward trend. It has increased from -13.00 Cr. (Jun 2025) to 106.00 Cr., marking an increase of 119.00 Cr..
- For Interest, as of Sep 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Jun 2025) to 9.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 9.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 95.00 Cr.. The value appears strong and on an upward trend. It has increased from -10.00 Cr. (Jun 2025) to 95.00 Cr., marking an increase of 105.00 Cr..
- For Tax %, as of Sep 2025, the value is 4.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Jun 2025) to 4.00%, marking a decrease of 28.00%.
- For Net Profit, as of Sep 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from -14.00 Cr. (Jun 2025) to 92.00 Cr., marking an increase of 106.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 21.39. The value appears strong and on an upward trend. It has increased from -1.79 (Jun 2025) to 21.39, marking an increase of 23.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:06 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 541 | 531 | 565 | 702 | 837 | 1,072 | 1,005 | 1,095 | 1,369 | 1,578 | 1,475 | 1,537 | 1,190 |
| Expenses | 500 | 506 | 533 | 675 | 802 | 1,008 | 977 | 1,001 | 1,301 | 1,506 | 1,423 | 1,505 | 1,149 |
| Operating Profit | 41 | 25 | 32 | 27 | 35 | 64 | 28 | 94 | 68 | 72 | 52 | 31 | 41 |
| OPM % | 8% | 5% | 6% | 4% | 4% | 6% | 3% | 9% | 5% | 5% | 4% | 2% | 3% |
| Other Income | 43 | 27 | 15 | 7 | 45 | 7 | 22 | 8 | 29 | 10 | 16 | -19 | 67 |
| Interest | 17 | 9 | 14 | 20 | 24 | 36 | 37 | 32 | 27 | 36 | 43 | 46 | 39 |
| Depreciation | 24 | 30 | 34 | 45 | 47 | 49 | 56 | 58 | 57 | 59 | 59 | 63 | 50 |
| Profit before tax | 43 | 13 | -1 | -32 | 10 | -15 | -43 | 11 | 13 | -12 | -34 | -96 | 20 |
| Tax % | 20% | 7% | 414% | -25% | -20% | 30% | -26% | -40% | 83% | 5% | 61% | 12% | |
| Net Profit | 34 | 12 | -7 | -24 | 12 | -20 | -32 | 16 | 2 | -13 | -55 | -108 | 9 |
| EPS in Rs | 7.72 | 2.82 | -1.65 | -3.38 | 3.22 | -3.42 | -5.90 | 3.32 | 1.56 | -2.01 | -8.79 | -19.13 | 7.45 |
| Dividend Payout % | 19% | 53% | -91% | -44% | 47% | -22% | 0% | 0% | 64% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -64.71% | -158.33% | -242.86% | 150.00% | -266.67% | -60.00% | 150.00% | -87.50% | -750.00% | -323.08% | -96.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | -93.63% | -84.52% | 392.86% | -416.67% | 206.67% | 210.00% | -237.50% | -662.50% | 426.92% | 226.71% |
Kanoria Chemicals & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 4% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 16% |
| 3 Years: | -20% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -3% |
| 3 Years: | -7% |
| Last Year: | -11% |
Last Updated: September 5, 2025, 8:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:30 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 474 | 472 | 581 | 558 | 566 | 577 | 547 | 565 | 577 | 584 | 579 | 499 | 510 |
| Borrowings | 161 | 331 | 430 | 408 | 440 | 509 | 539 | 493 | 475 | 510 | 509 | 595 | 327 |
| Other Liabilities | 152 | 157 | 192 | 222 | 250 | 293 | 266 | 282 | 329 | 366 | 380 | 382 | 249 |
| Total Liabilities | 810 | 982 | 1,225 | 1,209 | 1,278 | 1,401 | 1,374 | 1,362 | 1,403 | 1,481 | 1,490 | 1,498 | 1,108 |
| Fixed Assets | 328 | 344 | 512 | 743 | 800 | 850 | 894 | 864 | 863 | 882 | 850 | 865 | 709 |
| CWIP | 14 | 182 | 269 | 27 | 12 | 42 | 15 | 14 | 10 | 10 | 47 | 46 | 18 |
| Investments | 211 | 174 | 138 | 100 | 63 | 48 | 26 | 19 | 22 | 17 | 16 | 14 | 53 |
| Other Assets | 257 | 282 | 306 | 340 | 403 | 461 | 439 | 465 | 507 | 573 | 578 | 574 | 327 |
| Total Assets | 810 | 982 | 1,225 | 1,209 | 1,278 | 1,401 | 1,374 | 1,362 | 1,403 | 1,481 | 1,490 | 1,498 | 1,108 |
Below is a detailed analysis of the balance sheet data for Kanoria Chemicals & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00 Cr..
- For Reserves, as of Sep 2025, the value is 510.00 Cr.. The value appears strong and on an upward trend. It has increased from 499.00 Cr. (Mar 2025) to 510.00 Cr., marking an increase of 11.00 Cr..
- For Borrowings, as of Sep 2025, the value is 327.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 595.00 Cr. (Mar 2025) to 327.00 Cr., marking a decrease of 268.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 249.00 Cr.. The value appears to be improving (decreasing). It has decreased from 382.00 Cr. (Mar 2025) to 249.00 Cr., marking a decrease of 133.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,108.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,498.00 Cr. (Mar 2025) to 1,108.00 Cr., marking a decrease of 390.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 709.00 Cr.. The value appears to be declining and may need further review. It has decreased from 865.00 Cr. (Mar 2025) to 709.00 Cr., marking a decrease of 156.00 Cr..
- For CWIP, as of Sep 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 46.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 28.00 Cr..
- For Investments, as of Sep 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 53.00 Cr., marking an increase of 39.00 Cr..
- For Other Assets, as of Sep 2025, the value is 327.00 Cr.. The value appears to be declining and may need further review. It has decreased from 574.00 Cr. (Mar 2025) to 327.00 Cr., marking a decrease of 247.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,108.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,498.00 Cr. (Mar 2025) to 1,108.00 Cr., marking a decrease of 390.00 Cr..
Notably, the Reserves (510.00 Cr.) exceed the Borrowings (327.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -120.00 | -306.00 | -398.00 | -381.00 | -405.00 | -445.00 | -511.00 | -399.00 | -407.00 | -438.00 | -457.00 | -564.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 51 | 57 | 59 | 60 | 50 | 52 | 68 | 46 | 45 | 46 | 56 |
| Inventory Days | 101 | 82 | 86 | 87 | 92 | 96 | 97 | 84 | 97 | 91 | 104 | 84 |
| Days Payable | 77 | 66 | 53 | 77 | 84 | 74 | 85 | 77 | 80 | 75 | 82 | 78 |
| Cash Conversion Cycle | 82 | 68 | 89 | 69 | 68 | 71 | 64 | 75 | 63 | 61 | 68 | 63 |
| Working Capital Days | 43 | -7 | -8 | -5 | -8 | -2 | -7 | 16 | 17 | 8 | 9 | -4 |
| ROCE % | 5% | 1% | 1% | 1% | 3% | 2% | -1% | 4% | 4% | 1% | 1% | -2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| Diluted EPS (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| Cash EPS (Rs.) | -10.42 | 1.65 | 10.54 | 13.60 | 16.94 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 119.19 | 141.33 | 138.93 | 137.75 | 136.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.19 | 141.33 | 138.93 | 137.75 | 136.25 |
| Revenue From Operations / Share (Rs.) | 351.67 | 337.94 | 361.21 | 313.31 | 250.55 |
| PBDIT / Share (Rs.) | 9.29 | 16.47 | 18.92 | 22.20 | 24.16 |
| PBIT / Share (Rs.) | -5.04 | 2.17 | 5.44 | 9.11 | 10.88 |
| PBT / Share (Rs.) | -22.26 | -8.23 | -2.79 | 3.01 | 2.61 |
| Net Profit / Share (Rs.) | -24.75 | -12.65 | -2.95 | 0.51 | 3.66 |
| NP After MI And SOA / Share (Rs.) | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
| PBDIT Margin (%) | 2.64 | 4.87 | 5.23 | 7.08 | 9.64 |
| PBIT Margin (%) | -1.43 | 0.64 | 1.50 | 2.90 | 4.34 |
| PBT Margin (%) | -6.32 | -2.43 | -0.77 | 0.95 | 1.04 |
| Net Profit Margin (%) | -7.03 | -3.74 | -0.81 | 0.16 | 1.46 |
| NP After MI And SOA Margin (%) | -5.43 | -2.60 | -0.55 | 0.49 | 1.32 |
| Return on Networth / Equity (%) | -16.05 | -6.38 | -1.44 | 1.14 | 2.47 |
| Return on Capital Employeed (%) | -2.37 | 0.96 | 2.44 | 4.00 | 4.81 |
| Return On Assets (%) | -5.57 | -2.57 | -0.59 | 0.48 | 1.06 |
| Long Term Debt / Equity (X) | 0.65 | 0.49 | 0.52 | 0.57 | 0.58 |
| Total Debt / Equity (X) | 1.14 | 0.84 | 0.83 | 0.78 | 0.78 |
| Asset Turnover Ratio (%) | 1.03 | 0.99 | 1.09 | 0.57 | 0.34 |
| Current Ratio (X) | 0.99 | 1.11 | 1.12 | 1.24 | 1.22 |
| Quick Ratio (X) | 0.56 | 0.54 | 0.57 | 0.61 | 0.77 |
| Inventory Turnover Ratio (X) | 5.79 | 3.51 | 4.30 | 4.34 | 2.28 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | -49.84 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 8.70 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 149.84 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 91.30 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.88 | 1.67 | 2.30 | 3.64 | 3.27 |
| Interest Coverage Ratio (Post Tax) (X) | -0.73 | -0.22 | 0.64 | 1.08 | 1.61 |
| Enterprise Value (Cr.) | 900.35 | 972.38 | 951.81 | 1045.87 | 835.26 |
| EV / Net Operating Revenue (X) | 0.58 | 0.65 | 0.60 | 0.76 | 0.76 |
| EV / EBITDA (X) | 22.19 | 13.51 | 11.51 | 10.78 | 7.91 |
| MarketCap / Net Operating Revenue (X) | 0.21 | 0.31 | 0.29 | 0.43 | 0.36 |
| Retention Ratios (%) | 0.00 | 0.00 | 149.84 | 0.00 | 0.00 |
| Price / BV (X) | 0.62 | 0.76 | 0.76 | 0.99 | 0.67 |
| Price / Net Operating Revenue (X) | 0.21 | 0.31 | 0.29 | 0.43 | 0.36 |
| EarningsYield | -0.25 | -0.08 | -0.01 | 0.01 | 0.03 |
After reviewing the key financial ratios for Kanoria Chemicals & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 5. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 5. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For Cash EPS (Rs.), as of Mar 25, the value is -10.42. This value is below the healthy minimum of 3. It has decreased from 1.65 (Mar 24) to -10.42, marking a decrease of 12.07.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.19. It has decreased from 141.33 (Mar 24) to 119.19, marking a decrease of 22.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.19. It has decreased from 141.33 (Mar 24) to 119.19, marking a decrease of 22.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 351.67. It has increased from 337.94 (Mar 24) to 351.67, marking an increase of 13.73.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 9.29. This value is within the healthy range. It has decreased from 16.47 (Mar 24) to 9.29, marking a decrease of 7.18.
- For PBIT / Share (Rs.), as of Mar 25, the value is -5.04. This value is below the healthy minimum of 0. It has decreased from 2.17 (Mar 24) to -5.04, marking a decrease of 7.21.
- For PBT / Share (Rs.), as of Mar 25, the value is -22.26. This value is below the healthy minimum of 0. It has decreased from -8.23 (Mar 24) to -22.26, marking a decrease of 14.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -24.75. This value is below the healthy minimum of 2. It has decreased from -12.65 (Mar 24) to -24.75, marking a decrease of 12.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -19.13. This value is below the healthy minimum of 2. It has decreased from -8.79 (Mar 24) to -19.13, marking a decrease of 10.34.
- For PBDIT Margin (%), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 10. It has decreased from 4.87 (Mar 24) to 2.64, marking a decrease of 2.23.
- For PBIT Margin (%), as of Mar 25, the value is -1.43. This value is below the healthy minimum of 10. It has decreased from 0.64 (Mar 24) to -1.43, marking a decrease of 2.07.
- For PBT Margin (%), as of Mar 25, the value is -6.32. This value is below the healthy minimum of 10. It has decreased from -2.43 (Mar 24) to -6.32, marking a decrease of 3.89.
- For Net Profit Margin (%), as of Mar 25, the value is -7.03. This value is below the healthy minimum of 5. It has decreased from -3.74 (Mar 24) to -7.03, marking a decrease of 3.29.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 8. It has decreased from -2.60 (Mar 24) to -5.43, marking a decrease of 2.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is -16.05. This value is below the healthy minimum of 15. It has decreased from -6.38 (Mar 24) to -16.05, marking a decrease of 9.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.37. This value is below the healthy minimum of 10. It has decreased from 0.96 (Mar 24) to -2.37, marking a decrease of 3.33.
- For Return On Assets (%), as of Mar 25, the value is -5.57. This value is below the healthy minimum of 5. It has decreased from -2.57 (Mar 24) to -5.57, marking a decrease of 3.00.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.49 (Mar 24) to 0.65, marking an increase of 0.16.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.14. This value exceeds the healthy maximum of 1. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has increased from 0.99 (Mar 24) to 1.03, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1.5. It has decreased from 1.11 (Mar 24) to 0.99, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.56, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.79. This value is within the healthy range. It has increased from 3.51 (Mar 24) to 5.79, marking an increase of 2.28.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 3. It has decreased from 1.67 (Mar 24) to 0.88, marking a decrease of 0.79.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.73. This value is below the healthy minimum of 3. It has decreased from -0.22 (Mar 24) to -0.73, marking a decrease of 0.51.
- For Enterprise Value (Cr.), as of Mar 25, the value is 900.35. It has decreased from 972.38 (Mar 24) to 900.35, marking a decrease of 72.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.58, marking a decrease of 0.07.
- For EV / EBITDA (X), as of Mar 25, the value is 22.19. This value exceeds the healthy maximum of 15. It has increased from 13.51 (Mar 24) to 22.19, marking an increase of 8.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.31 (Mar 24) to 0.21, marking a decrease of 0.10.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.62, marking a decrease of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.31 (Mar 24) to 0.21, marking a decrease of 0.10.
- For EarningsYield, as of Mar 25, the value is -0.25. This value is below the healthy minimum of 5. It has decreased from -0.08 (Mar 24) to -0.25, marking a decrease of 0.17.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kanoria Chemicals & Industries Ltd:
- Net Profit Margin: -7.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.37% (Industry Average ROCE: 8.17%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -16.05% (Industry Average ROE: 9.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.73
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 22)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.14
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Alcohol Based | KCI Plaza, 6th Floor, Kolkata West Bengal 700019 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R V Kanoria | Chairman & Managing Director |
| Mr. S V Kanoria | Whole Time Director |
| Mr. H K Khaitan | Non Exe.Non Ind.Director |
| Mrs. Madhuvanti Kanoria | Non Exe.Non Ind.Director |
| Mr. Sidharth Kumar Birla | Ind. Non-Executive Director |
| Mrs. Suhana Murshed | Ind. Non-Executive Director |
| Mrs. Meeta Makhan | Ind. Non-Executive Director |
| Mr. Sumanta Chaudhuri | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Kanoria Chemicals & Industries Ltd?
Kanoria Chemicals & Industries Ltd's intrinsic value (as of 25 January 2026) is ₹240.90 which is 251.68% higher the current market price of ₹68.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹299 Cr. market cap, FY2025-2026 high/low of ₹110/64.8, reserves of ₹510 Cr, and liabilities of ₹1,108 Cr.
What is the Market Cap of Kanoria Chemicals & Industries Ltd?
The Market Cap of Kanoria Chemicals & Industries Ltd is 299 Cr..
What is the current Stock Price of Kanoria Chemicals & Industries Ltd as on 25 January 2026?
The current stock price of Kanoria Chemicals & Industries Ltd as on 25 January 2026 is ₹68.5.
What is the High / Low of Kanoria Chemicals & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kanoria Chemicals & Industries Ltd stocks is ₹110/64.8.
What is the Stock P/E of Kanoria Chemicals & Industries Ltd?
The Stock P/E of Kanoria Chemicals & Industries Ltd is .
What is the Book Value of Kanoria Chemicals & Industries Ltd?
The Book Value of Kanoria Chemicals & Industries Ltd is 122.
What is the Dividend Yield of Kanoria Chemicals & Industries Ltd?
The Dividend Yield of Kanoria Chemicals & Industries Ltd is 0.00 %.
What is the ROCE of Kanoria Chemicals & Industries Ltd?
The ROCE of Kanoria Chemicals & Industries Ltd is 2.33 %.
What is the ROE of Kanoria Chemicals & Industries Ltd?
The ROE of Kanoria Chemicals & Industries Ltd is 11.8 %.
What is the Face Value of Kanoria Chemicals & Industries Ltd?
The Face Value of Kanoria Chemicals & Industries Ltd is 5.00.